114 related articles for article (PubMed ID: 23882694)
1. Anti-retinal antibodies in patients with macular telangiectasia type 2.
Zhu L; Shen W; Zhu M; Coorey NJ; Nguyen AP; Barthelmes D; Gillies MC
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5675-83. PubMed ID: 23882694
[TBL] [Abstract][Full Text] [Related]
2. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
[TBL] [Abstract][Full Text] [Related]
3. Demographic features of idiopathic macular telangiectasia in Korean patients.
Kim SH; Oh J; Ahn SE; Park CY; Oh JH
Korean J Ophthalmol; 2015 Jun; 29(3):155-9. PubMed ID: 26028942
[TBL] [Abstract][Full Text] [Related]
4. Identification of anti-retinal antibodies in patients with age-related macular degeneration.
Morohoshi K; Ohbayashi M; Patel N; Chong V; Bird AC; Ono SJ
Exp Mol Pathol; 2012 Oct; 93(2):193-9. PubMed ID: 22465421
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cell-mediated immune response against human retinal antigens in relation to ocular onchocerciasis.
Van der Lelij A; Rothova A; Stilma JS; Vetter JC; Hoekzema R; Kijlstra A
Acta Leiden; 1990; 59(1-2):271-83. PubMed ID: 2378211
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
7. Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.
Clemons TE; Gillies MC; Chew EY; Bird AC; Peto T; Wang JJ; Mitchell P; Ramdas WD; Vingerling JR;
Ophthalmic Epidemiol; 2013 Apr; 20(2):109-13. PubMed ID: 23510315
[TBL] [Abstract][Full Text] [Related]
8. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).
Umeda S; Suzuki MT; Okamoto H; Ono F; Mizota A; Terao K; Yoshikawa Y; Tanaka Y; Iwata T
FASEB J; 2005 Oct; 19(12):1683-5. PubMed ID: 16099945
[TBL] [Abstract][Full Text] [Related]
9. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
[TBL] [Abstract][Full Text] [Related]
10. The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life.
Lamoureux EL; Maxwell RM; Marella M; Dirani M; Fenwick E; Guymer RH
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2520-4. PubMed ID: 21217104
[TBL] [Abstract][Full Text] [Related]
11. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration.
Patel N; Ohbayashi M; Nugent AK; Ramchand K; Toda M; Chau KY; Bunce C; Webster A; Bird AC; Ono SJ; Chong V
Immunology; 2005 Jul; 115(3):422-30. PubMed ID: 15946260
[TBL] [Abstract][Full Text] [Related]
12. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.
Grus FH; Joachim SC; Bruns K; Lackner KJ; Pfeiffer N; Wax MB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):968-76. PubMed ID: 16505031
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of type 2 idiopathic macular telangiectasia in two African populations.
Sallo FB; Leung I; Mathenge W; Kyari F; Kuper H; Gilbert CE; Bird AC; Peto T;
Ophthalmic Epidemiol; 2012 Aug; 19(4):185-9. PubMed ID: 22364548
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against human retinal proteins in serum from patients with cone dystrophy.
Isashiki Y; Ohba N; Nakagawa M; Miyake Y
Jpn J Ophthalmol; 1992; 36(3):323-30. PubMed ID: 1464972
[TBL] [Abstract][Full Text] [Related]
15. Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.
Wolf-Schnurrbusch UEK; Leung I; Sallo FB; Clemons TE; Chew EY; Bird AC; Peto T;
Ophthalmic Res; 2018; 60(1):38-42. PubMed ID: 28903123
[TBL] [Abstract][Full Text] [Related]
16. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
17. Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension.
Reichelt J; Joachim SC; Pfeiffer N; Grus FH
Curr Eye Res; 2008 Mar; 33(3):253-61. PubMed ID: 18350436
[TBL] [Abstract][Full Text] [Related]
18. Frequency of anti-retinal antibodies in normal human serum.
Shimazaki K; Jirawuthiworavong GV; Heckenlively JR; Gordon LK
J Neuroophthalmol; 2008 Mar; 28(1):5-11. PubMed ID: 18347451
[TBL] [Abstract][Full Text] [Related]
19. Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
Morohoshi K; Patel N; Ohbayashi M; Chong V; Grossniklaus HE; Bird AC; Ono SJ
Exp Mol Pathol; 2012 Feb; 92(1):64-73. PubMed ID: 22001380
[TBL] [Abstract][Full Text] [Related]
20. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
